Akero Therapeutics
AKRO
AKRO
67 hedge funds and large institutions have $468M invested in Akero Therapeutics in 2020 Q1 according to their latest regulatory filings, with 19 funds opening new positions, 23 increasing their positions, 16 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
11% more capital invested
Capital invested by funds: $422M → $468M (+$46M)
10.58% more ownership
Funds ownership: 66.53% → 77.1% (+11%)
91% less call options, than puts
Call options by funds: $324K | Put options by funds: $3.48M
Holders
67
Holding in Top 10
4
Calls
$324K
Puts
$3.48M
Top Buyers
| 1 | +$58M | |
| 2 | +$17.1M | |
| 3 | +$10.6M | |
| 4 |
Alkeon Capital Management
New York
|
+$10.3M |
| 5 |
Janus Henderson Group
London,
United Kingdom
|
+$7.57M |
Top Sellers
| 1 | -$16.8M | |
| 2 | -$12.6M | |
| 3 | -$12M | |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
-$5.47M |
| 5 |
BI
BVF Inc
San Francisco,
California
|
-$3.56M |